首页 > 最新文献

Medicina-Lithuania最新文献

英文 中文
Factors Associated with Mortality Risk in Patients with Cardiogenic Shock Post-ST-Elevation Myocardial Infarction: Insights from a Regional Centre in Northwest Romania. 与st段抬高型心肌梗死后心源性休克患者死亡风险相关的因素:来自罗马尼亚西北部地区中心的见解
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-14 DOI: 10.3390/medicina61040725
Călin Florin Pop, Camelia Alexandra Coadă, Mihai Lupu, Ioan Florin Ferenț, Roxana Ioana Hodas, Andreea Pintilie, Mădălina-Ştefana Ursu

Background and Objectives: ST elevation myocardial infarction (STEMI), particularly when complicated by cardiogenic shock (CS), is a critical condition associated with high mortality rates. Identifying predictors of in-hospital mortality can enhance patient management and outcomes. Materials and Methods: This observational, retrospective case-control study included STEMI patients, both complicated and uncomplicated by CS. Additionally, demographics, clinical characteristics, laboratory data and in-hospital mortality rates were analysed for STEMI patients with CS and those without CS. Results: This study included a total of 101 patients with STEMI, of whom 51 (50.5%) had STEMI without CS and 50 (49.5%) had STEMI with CS. No significant differences were observed in demographic characteristics or STEMI risk factors between the two groups. Emergency coronarography was performed in 90.1% of the patients, with successful thrombolysis achieved in 24.5%. Patients with CS exhibited a significantly higher mortality (52%) than those without CS (11.76%). Univariate analysis identified white blood cell counts, CK-MB, CK levels, elevated creatinine and uric acid levels and a reduced left ventricular ejection fraction (LVEF) as predictors of mortality. Logistic regression analysis revealed that LVEF and CK-MB were independent predictors of in-hospital mortality in patients with STEMI and CS. Each 1% increase in LVEF was associated with a reduced mortality risk (HR = 0.89; 95% CI 0.81-0.98; p = 0.018), while elevated CK-MB levels were linked to an increased mortality risk (HR = 1; 95% CI 1-1.01; p = 0.014). Conclusions: Reduced systolic function and elevated CK-MB levels are key predictors of in-hospital mortality and outcomes in STEMI patients with CS. These findings underscore the importance of early identification and support the development of targeted management strategies aimed at improving outcomes in this high-risk population.

背景和目的:ST段抬高型心肌梗死(STEMI),尤其是合并心源性休克(CS)时,是一种与高死亡率相关的危重疾病。确定院内死亡率的预测因素可以提高患者管理和预后。材料和方法:这项观察性、回顾性的病例对照研究纳入了STEMI患者,包括合并和未合并CS的患者。此外,还分析了STEMI合并CS和非CS患者的人口统计学、临床特征、实验室数据和住院死亡率。结果:本研究共纳入101例STEMI患者,其中51例(50.5%)为STEMI不伴CS, 50例(49.5%)为STEMI伴CS。两组患者的人口学特征和STEMI危险因素无显著差异。90.1%的患者进行了急诊冠状造影,24.5%的患者成功溶栓。CS患者的死亡率(52%)明显高于非CS患者(11.76%)。单变量分析确定白细胞计数、CK- mb、CK水平、肌酐和尿酸水平升高以及左心室射血分数(LVEF)降低是死亡率的预测因子。Logistic回归分析显示LVEF和CK-MB是STEMI和CS患者住院死亡率的独立预测因子。LVEF每增加1%与死亡风险降低相关(HR = 0.89;95% ci 0.81-0.98;p = 0.018),而CK-MB水平升高与死亡风险增加有关(HR = 1;95% ci 1-1.01;P = 0.014)。结论:收缩功能降低和CK-MB水平升高是STEMI合并CS患者住院死亡率和预后的关键预测因素。这些发现强调了早期识别的重要性,并支持制定有针对性的管理策略,旨在改善这一高危人群的预后。
{"title":"Factors Associated with Mortality Risk in Patients with Cardiogenic Shock Post-ST-Elevation Myocardial Infarction: Insights from a Regional Centre in Northwest Romania.","authors":"Călin Florin Pop, Camelia Alexandra Coadă, Mihai Lupu, Ioan Florin Ferenț, Roxana Ioana Hodas, Andreea Pintilie, Mădălina-Ştefana Ursu","doi":"10.3390/medicina61040725","DOIUrl":"https://doi.org/10.3390/medicina61040725","url":null,"abstract":"<p><p><i>Background and Objectives</i>: ST elevation myocardial infarction (STEMI), particularly when complicated by cardiogenic shock (CS), is a critical condition associated with high mortality rates. Identifying predictors of in-hospital mortality can enhance patient management and outcomes. <i>Materials and Methods</i>: This observational, retrospective case-control study included STEMI patients, both complicated and uncomplicated by CS. Additionally, demographics, clinical characteristics, laboratory data and in-hospital mortality rates were analysed for STEMI patients with CS and those without CS. <i>Results</i>: This study included a total of 101 patients with STEMI, of whom 51 (50.5%) had STEMI without CS and 50 (49.5%) had STEMI with CS. No significant differences were observed in demographic characteristics or STEMI risk factors between the two groups. Emergency coronarography was performed in 90.1% of the patients, with successful thrombolysis achieved in 24.5%. Patients with CS exhibited a significantly higher mortality (52%) than those without CS (11.76%). Univariate analysis identified white blood cell counts, CK-MB, CK levels, elevated creatinine and uric acid levels and a reduced left ventricular ejection fraction (LVEF) as predictors of mortality. Logistic regression analysis revealed that LVEF and CK-MB were independent predictors of in-hospital mortality in patients with STEMI and CS. Each 1% increase in LVEF was associated with a reduced mortality risk (HR = 0.89; 95% CI 0.81-0.98; <i>p</i> = 0.018), while elevated CK-MB levels were linked to an increased mortality risk (HR = 1; 95% CI 1-1.01; <i>p</i> = 0.014). <i>Conclusions</i>: Reduced systolic function and elevated CK-MB levels are key predictors of in-hospital mortality and outcomes in STEMI patients with CS. These findings underscore the importance of early identification and support the development of targeted management strategies aimed at improving outcomes in this high-risk population.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12029066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of Dietary Supplements in People with the Atopic Triad in Korea: A Cross-Sectional Study Using KNHANES (2018-2021). 韩国特应性三联征患者膳食补充剂的使用:一项使用KNHANES的横断面研究(2018-2021)。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-13 DOI: 10.3390/medicina61040718
Hyunjoo Kim, Heesoo Bang, Eunkyung Euni Lee

Background and Objectives: Studies investigating the types of dietary supplements associated with the atopic triad using large-scale data remain limited. We assessed the prevalence of the atopic triad, the types of dietary supplements used, and their associations in Korean adults using a 4-year national survey data. Materials and Methods: This cross-sectional study utilized data from the Korea National Health and Nutrition Examination Survey (2018-2021). Adults aged ≥ 19 years were included. Descriptive statistics were used to summarize participants' overall characteristics and estimate the national prevalence of the atopic triad, defined as a diagnosis of asthma, allergic rhinitis, or atopic dermatitis. Logistic regression analyses were conducted using each atopic condition as a dependent variable, with the types of dietary supplements currently used as independent variables. Covariates included socioeconomic status, lifestyle factors, frailty, and diet. Dietary supplements were categorized as multivitamins/minerals, vitamin C, vitamin D, vitamin A/lutein, propolis, omega-3, probiotics, red ginseng, calcium, or iron. Results: A total of 18,182 adults were analyzed, representing an estimated 52.8 million adults (mean age: 47 years; 50% male). Of these, 21% reported a history of any atopic triad, and 61% were current supplement users. Logistic regression showed significantly higher odds of all three atopic conditions among users of propolis (asthma: OR 1.90, 95% CI 1.04-3.47; allergic rhinitis: OR 1.64, 95% CI 1.25-2.17; atopic dermatitis: OR 2.04, 95% CI: 1.18-3.52), and higher odds of allergic rhinitis among users of probiotics (OR 1.21, 95% CI 1.06-1.38) and vitamin D (OR 1.43, 95% CI 1.16-1.75). Conclusions: A positive association was found between propolis use and all three atopic conditions. Also, a positive association was found between probiotics or vitamin D use and allergic rhinitis. We did not find significant associations with the other supplements. Further research in establishing causal relationships between the dietary supplements and atopic conditions are needed.

背景和目的:利用大规模数据调查与特应性三联征相关的膳食补充剂类型的研究仍然有限。我们利用一项为期4年的全国调查数据,评估了韩国成年人中特应性三联征的患病率、所使用的膳食补充剂类型及其相关性。材料和方法:本横断面研究使用了韩国国家健康和营养检查调查(2018-2021)的数据。纳入年龄≥19岁的成年人。描述性统计用于总结参与者的总体特征,并估计特应性三联征的全国患病率,特应性三联征被定义为哮喘、过敏性鼻炎或特应性皮炎的诊断。使用每个特应性疾病作为因变量进行逻辑回归分析,目前使用的膳食补充剂类型作为自变量。协变量包括社会经济地位、生活方式因素、体质和饮食。膳食补充剂被归类为多种维生素/矿物质、维生素C、维生素D、维生素A/叶黄素、蜂胶、omega-3、益生菌、红参、钙或铁。结果:共分析了18182名成年人,代表了大约5280万成年人(平均年龄:47岁;50%的男性)。其中,21%的人报告有任何特应性三联征的病史,61%的人目前是补充剂的使用者。Logistic回归结果显示,蜂胶使用者发生三种特应性疾病的几率显著增加(哮喘:OR 1.90, 95% CI 1.04-3.47;变应性鼻炎:OR 1.64, 95% CI 1.25-2.17;特应性皮炎:OR 2.04, 95% CI: 1.18-3.52),而使用益生菌(OR 1.21, 95% CI 1.06-1.38)和维生素D (OR 1.43, 95% CI 1.16-1.75)的人患变应性鼻炎的几率更高。结论:蜂胶的使用与所有三种特应性疾病呈正相关。此外,益生菌或维生素D的使用与过敏性鼻炎之间存在正相关。我们没有发现与其他补充剂有显著关联。需要进一步研究确定膳食补充剂与特应性疾病之间的因果关系。
{"title":"Utilization of Dietary Supplements in People with the Atopic Triad in Korea: A Cross-Sectional Study Using KNHANES (2018-2021).","authors":"Hyunjoo Kim, Heesoo Bang, Eunkyung Euni Lee","doi":"10.3390/medicina61040718","DOIUrl":"https://doi.org/10.3390/medicina61040718","url":null,"abstract":"<p><p><i>Background and Objectives</i>: Studies investigating the types of dietary supplements associated with the atopic triad using large-scale data remain limited. We assessed the prevalence of the atopic triad, the types of dietary supplements used, and their associations in Korean adults using a 4-year national survey data. <i>Materials and Methods</i>: This cross-sectional study utilized data from the Korea National Health and Nutrition Examination Survey (2018-2021). Adults aged ≥ 19 years were included. Descriptive statistics were used to summarize participants' overall characteristics and estimate the national prevalence of the atopic triad, defined as a diagnosis of asthma, allergic rhinitis, or atopic dermatitis. Logistic regression analyses were conducted using each atopic condition as a dependent variable, with the types of dietary supplements currently used as independent variables. Covariates included socioeconomic status, lifestyle factors, frailty, and diet. Dietary supplements were categorized as multivitamins/minerals, vitamin C, vitamin D, vitamin A/lutein, propolis, omega-3, probiotics, red ginseng, calcium, or iron. <i>Results</i>: A total of 18,182 adults were analyzed, representing an estimated 52.8 million adults (mean age: 47 years; 50% male). Of these, 21% reported a history of any atopic triad, and 61% were current supplement users. Logistic regression showed significantly higher odds of all three atopic conditions among users of propolis (asthma: OR 1.90, 95% CI 1.04-3.47; allergic rhinitis: OR 1.64, 95% CI 1.25-2.17; atopic dermatitis: OR 2.04, 95% CI: 1.18-3.52), and higher odds of allergic rhinitis among users of probiotics (OR 1.21, 95% CI 1.06-1.38) and vitamin D (OR 1.43, 95% CI 1.16-1.75). <i>Conclusions</i>: A positive association was found between propolis use and all three atopic conditions. Also, a positive association was found between probiotics or vitamin D use and allergic rhinitis. We did not find significant associations with the other supplements. Further research in establishing causal relationships between the dietary supplements and atopic conditions are needed.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028613/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Modulation Through Stereotactic Radiotherapy: The Role of TBX21, GATA-3, FoxP3, and RORɣt. 立体定向放疗的免疫调节:TBX21、GATA-3、FoxP3和ROR的作用。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-13 DOI: 10.3390/medicina61040717
Aybala Nur Ucgul, Huseyin Bora, Gizem Yaz Aydin, Ozlem Gulbahar, Ummu Habibe Koken

Background and Objectives: Stereotactic radiotherapy enhances local tumor control by delivering high doses directly to the tumor. It is thought to activate the immune system via T-cells, possibly creating a systemic response. This study aims to evaluate stereotactic body radiotherapy's (SBRT) impact on the immune system by measuring T-cell transcription factors, such as TBX21, GATA-3, FoxP3, and RORɣt. Materials and Methods: Peripheral blood samples were collected from 103 patients before SBRT and from 66 patients two months post-treatment. We measured transcription factors TBX21, GATA-3, FOXP3, and RORγt using ELISA, and performed a complete blood count and C-reactive protein analysis to rule out infections. Statistical analyses included paired t-tests and correlation analyses to assess changes before and after treatment. Results: Post-treatment, significant reductions were observed in TBX21 (Th1), GATA-3 (Th2), and FOXP3 (Treg), while RORɣt (Th17) remained stable but trended higher in lung cancer patients. No correlations were found with demographic factors. However, TBX21 levels were significantly related to the planning target volume (PTV) and biologically effective dose (BED10) in the lung region. Larger PTVs (≥16.5 cc) and higher BED10 doses (≥100 Gy) were linked to smaller reductions in TBX21 (p = 0.008, p = 0.04) and increased RORɣt levels (p = 0.01). Conclusions: Stereotactic radiotherapy reduces immunosuppressive markers like FOXP3 and GATA-3, indicating its potential to boost immune activation by suppressing Treg and Th2 cells. Larger target volumes and higher BED10 values may enhance Th1 responses through TBX21. These findings suggest that SBRT activates the immune system, and its combination with immunotherapy could be promising.

背景和目的:立体定向放射治疗通过直接向肿瘤输送高剂量来增强肿瘤的局部控制。它被认为通过t细胞激活免疫系统,可能产生全身反应。本研究旨在通过测量t细胞转录因子TBX21、gta -3、FoxP3和ROR α t来评估立体定向体放疗(SBRT)对免疫系统的影响。材料与方法:103例患者在SBRT治疗前和66例患者治疗2个月后采集外周血。我们使用ELISA检测转录因子TBX21、gada -3、FOXP3和rorγ - t,并进行全血细胞计数和c反应蛋白分析以排除感染。统计分析包括配对t检验和相关分析,以评估治疗前后的变化。结果:治疗后,肺癌患者TBX21 (Th1)、gta -3 (Th2)、FOXP3 (Treg)显著降低,ROR α t (Th17)保持稳定,但有升高趋势。与人口统计学因素无相关性。TBX21水平与肺区规划靶体积(PTV)和生物有效剂量(BED10)显著相关。较大的PTVs(≥16.5 cc)和较高的BED10剂量(≥100 Gy)与TBX21的较小降低(p = 0.008, p = 0.04)和ROR α t水平升高(p = 0.01)相关。结论:立体定向放疗可降低FOXP3和gada -3等免疫抑制标志物,表明其可能通过抑制Treg和Th2细胞来促进免疫激活。更大的靶体积和更高的BED10值可能通过TBX21增强Th1的响应。这些发现表明,SBRT激活免疫系统,其与免疫疗法的结合可能是有希望的。
{"title":"Immune Modulation Through Stereotactic Radiotherapy: The Role of TBX21, GATA-3, FoxP3, and RORɣt.","authors":"Aybala Nur Ucgul, Huseyin Bora, Gizem Yaz Aydin, Ozlem Gulbahar, Ummu Habibe Koken","doi":"10.3390/medicina61040717","DOIUrl":"https://doi.org/10.3390/medicina61040717","url":null,"abstract":"<p><p><i>Background and Objectives</i>: Stereotactic radiotherapy enhances local tumor control by delivering high doses directly to the tumor. It is thought to activate the immune system via T-cells, possibly creating a systemic response. This study aims to evaluate stereotactic body radiotherapy's (SBRT) impact on the immune system by measuring T-cell transcription factors, such as TBX21, GATA-3, FoxP3, and RORɣt. <i>Materials and Methods</i>: Peripheral blood samples were collected from 103 patients before SBRT and from 66 patients two months post-treatment. We measured transcription factors TBX21, GATA-3, FOXP3, and RORγt using ELISA, and performed a complete blood count and C-reactive protein analysis to rule out infections. Statistical analyses included paired <i>t</i>-tests and correlation analyses to assess changes before and after treatment. <i>Results</i>: Post-treatment, significant reductions were observed in TBX21 (Th1), GATA-3 (Th2), and FOXP3 (Treg), while RORɣt (Th17) remained stable but trended higher in lung cancer patients. No correlations were found with demographic factors. However, TBX21 levels were significantly related to the planning target volume (PTV) and biologically effective dose (BED10) in the lung region. Larger PTVs (≥16.5 cc) and higher BED10 doses (≥100 Gy) were linked to smaller reductions in TBX21 (<i>p</i> = 0.008, <i>p</i> = 0.04) and increased RORɣt levels (<i>p</i> = 0.01). <i>Conclusions</i>: Stereotactic radiotherapy reduces immunosuppressive markers like FOXP3 and GATA-3, indicating its potential to boost immune activation by suppressing Treg and Th2 cells. Larger target volumes and higher BED10 values may enhance Th1 responses through TBX21. These findings suggest that SBRT activates the immune system, and its combination with immunotherapy could be promising.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144023336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Klintrup-Mäkinen (KM) Score in Gastric Cancer and Its Association with Pathological Parameters. Klintrup-Mäkinen (KM)评分对胃癌预后的影响及其与病理参数的关系
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-13 DOI: 10.3390/medicina61040715
Andreea-Raluca Cozac-Szőke, Georgian-Nicolae Radu, Anca Negovan, Dan Alexandru Cozac, Sabin Turdean, Andreea-Cătălina Tinca, Emőke-Andrea Szász, Iuliu-Gabriel Cocuz, Adrian-Horațiu Sabău, Raluca Niculescu, Diana Maria Chiorean, Alexandru Nicușor Tomuț, Ovidiu Simion Cotoi

Background and Objectives: Gastric cancer (GC) remains a significant global health challenge with a poor prognosis. This study aimed to evaluate the association between Klintrup-Mäkinen (KM) inflammatory infiltrate grading and clinicopathological features in gastric cancer patients, investigating its potential as a prognostic marker. Material and Methods: This retrospective study analyzed 133 gastric adenocarcinoma patients diagnosed between 2020 and 2021 at County Clinical Hospital in Târgu Mureș, Romania. Patients were divided into two groups based on KM grades: low (grades 0-1, n = 62) and high (grades 2-3, n = 71). Clinicopathological characteristics and survival outcomes were compared between the groups. Results: Demographic characteristics were similar between the groups. Patients with low KM grades demonstrated significantly more aggressive tumor features, including a higher prevalence of Borrmann classification types III-IV (75.8% vs. 54.9%, p = 0.01), poorly differentiated histology (74.1% vs. 33.8%, p < 0.0001), advanced T stage (93.5% vs. 80.2%, p = 0.04), and lymph node involvement (87% vs. 60.5%, p = 0.0008). This group also exhibited higher rates of lymphatic invasion (79% vs. 50.7%, p = 0.001), venous invasion (51.6% vs. 30.9%, p = 0.02), perineural invasion (50% vs. 22.5%, p = 0.001), and positive surgical margins (32.2% vs. 15.4%, p = 0.02). Survival analysis revealed a hazard ratio of 1.642 (95% CI: 1.02-2.62) for patients with low KM grades compared to those with high KM grades. Conclusions: Low KM grades are associated with more aggressive tumor characteristics and poorer prognosis in GC patients. The KM score may serve as a valuable, cost-effective histological marker for assessing tumor aggressiveness and could aid in risk stratification when applied to routine H&E-stained slides. While it does not replace immunohistochemical or molecular analyses, integrating the KM score into pathological assessment may enhance prognostic accuracy and support identifying patients who might benefit from immunotherapy.

背景和目的:胃癌(GC)仍然是一个重大的全球健康挑战,预后不良。本研究旨在评估Klintrup-Mäkinen (KM)炎症浸润分级与胃癌患者临床病理特征之间的关系,探讨其作为预后指标的潜力。材料和方法:本回顾性研究分析了2020年至2021年在罗马尼亚穆列乌斯县临床医院诊断的133例胃腺癌患者。患者根据KM等级分为两组:低(0-1级,n = 62)和高(2-3级,n = 71)。比较两组患者的临床病理特征和生存结局。结果:两组人口统计学特征相似。KM级别低的患者表现出更具有侵袭性的肿瘤特征,包括Borrmann分类III-IV型(75.8%比54.9%,p = 0.01)、低分化组织学(74.1%比33.8%,p < 0.0001)、晚期T期(93.5%比80.2%,p = 0.04)和淋巴结累及(87%比60.5%,p = 0.0008)的患病率更高。该组淋巴浸润率(79%比50.7%,p = 0.001)、静脉浸润率(51.6%比30.9%,p = 0.02)、神经周围浸润率(50%比22.5%,p = 0.001)和手术切缘阳性率(32.2%比15.4%,p = 0.02)也较高。生存分析显示,与高KM分级患者相比,低KM分级患者的风险比为1.642 (95% CI: 1.02-2.62)。结论:低KM分级与胃癌患者更具侵袭性的肿瘤特征和较差的预后相关。KM评分可以作为评估肿瘤侵袭性的一种有价值的、具有成本效益的组织学标记物,当应用于常规h&e染色玻片时,可以帮助进行风险分层。虽然它不能取代免疫组织化学或分子分析,但将KM评分整合到病理评估中可以提高预后准确性,并支持识别可能受益于免疫治疗的患者。
{"title":"Prognostic Impact of Klintrup-Mäkinen (KM) Score in Gastric Cancer and Its Association with Pathological Parameters.","authors":"Andreea-Raluca Cozac-Szőke, Georgian-Nicolae Radu, Anca Negovan, Dan Alexandru Cozac, Sabin Turdean, Andreea-Cătălina Tinca, Emőke-Andrea Szász, Iuliu-Gabriel Cocuz, Adrian-Horațiu Sabău, Raluca Niculescu, Diana Maria Chiorean, Alexandru Nicușor Tomuț, Ovidiu Simion Cotoi","doi":"10.3390/medicina61040715","DOIUrl":"https://doi.org/10.3390/medicina61040715","url":null,"abstract":"<p><p><i>Background and Objectives:</i> Gastric cancer (GC) remains a significant global health challenge with a poor prognosis. This study aimed to evaluate the association between Klintrup-Mäkinen (KM) inflammatory infiltrate grading and clinicopathological features in gastric cancer patients, investigating its potential as a prognostic marker. <i>Material and Methods:</i> This retrospective study analyzed 133 gastric adenocarcinoma patients diagnosed between 2020 and 2021 at County Clinical Hospital in Târgu Mureș, Romania. Patients were divided into two groups based on KM grades: low (grades 0-1, <i>n</i> = 62) and high (grades 2-3, <i>n</i> = 71). Clinicopathological characteristics and survival outcomes were compared between the groups. <i>Results:</i> Demographic characteristics were similar between the groups. Patients with low KM grades demonstrated significantly more aggressive tumor features, including a higher prevalence of Borrmann classification types III-IV (75.8% vs. 54.9%, <i>p</i> = 0.01), poorly differentiated histology (74.1% vs. 33.8%, <i>p</i> < 0.0001), advanced T stage (93.5% vs. 80.2%, <i>p</i> = 0.04), and lymph node involvement (87% vs. 60.5%, <i>p</i> = 0.0008). This group also exhibited higher rates of lymphatic invasion (79% vs. 50.7%, <i>p</i> = 0.001), venous invasion (51.6% vs. 30.9%, <i>p</i> = 0.02), perineural invasion (50% vs. 22.5%, <i>p</i> = 0.001), and positive surgical margins (32.2% vs. 15.4%, <i>p</i> = 0.02). Survival analysis revealed a hazard ratio of 1.642 (95% CI: 1.02-2.62) for patients with low KM grades compared to those with high KM grades. <i>Conclusions:</i> Low KM grades are associated with more aggressive tumor characteristics and poorer prognosis in GC patients. The KM score may serve as a valuable, cost-effective histological marker for assessing tumor aggressiveness and could aid in risk stratification when applied to routine H&E-stained slides. While it does not replace immunohistochemical or molecular analyses, integrating the KM score into pathological assessment may enhance prognostic accuracy and support identifying patients who might benefit from immunotherapy.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12029010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma. 液体活检作为胶质母细胞瘤的诊断和监测工具。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-13 DOI: 10.3390/medicina61040716
Ligia Gabriela Tataranu

Glioblastoma (GBM) is the most prevalent and aggressive primary central nervous system (CNS) tumor in adults. GBMs exhibit genetic and epigenetic heterogeneity, posing difficulties in surveillance and being associated with high rates of recurrence and mortality. Nevertheless, due to the high infiltrating ability of glioblastoma cells, and regardless of the considerable progress made in radiotherapeutic, chemotherapeutic, and surgical protocols, the treatment of GBM is still inefficient. Conventional diagnostic approaches, such as neuroimaging techniques and tissue biopsies, which are invasive maneuvers, present certain challenges and limitations in providing real-time information, and are incapable of differentiating pseudo-progression related to treatment from real tumor progression. Liquid biopsy, the analysis of biomarkers such as nucleic acids (DNA/RNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), or tumor-educated platelets (TEPs) that are present in body fluids, provides a minimally invasive and dynamic method of diagnosis and continuous monitoring for GBM. It represents a new preferred approach that enables a superior manner to obtain data on possible tumor risk, prognosis, and recurrence assessment. This article is a literature review that aims to provide updated information about GBM biomarkers in body fluids and to analyze their clinical efficiency.

胶质母细胞瘤(GBM)是成人中最常见和侵袭性最强的原发性中枢神经系统(CNS)肿瘤。GBMs表现出遗传和表观遗传异质性,给监测带来困难,并与高复发率和死亡率相关。然而,由于胶质母细胞瘤细胞的高浸润能力,尽管在放疗、化疗和手术方案方面取得了相当大的进展,但对GBM的治疗仍然效率低下。传统的诊断方法,如神经成像技术和组织活检,是侵入性的,在提供实时信息方面存在一定的挑战和局限性,并且无法区分与治疗相关的假进展和真实肿瘤进展。液体活检,分析生物标志物,如核酸(DNA/RNA)、循环肿瘤细胞(ctc)、细胞外囊泡(ev)或存在于体液中的肿瘤诱导血小板(TEPs),为GBM的诊断和持续监测提供了一种微创和动态的方法。它代表了一种新的首选方法,能够以优越的方式获得关于可能的肿瘤风险、预后和复发评估的数据。本文是一篇文献综述,旨在提供体液中GBM生物标志物的最新信息并分析其临床疗效。
{"title":"Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma.","authors":"Ligia Gabriela Tataranu","doi":"10.3390/medicina61040716","DOIUrl":"https://doi.org/10.3390/medicina61040716","url":null,"abstract":"<p><p>Glioblastoma (GBM) is the most prevalent and aggressive primary central nervous system (CNS) tumor in adults. GBMs exhibit genetic and epigenetic heterogeneity, posing difficulties in surveillance and being associated with high rates of recurrence and mortality. Nevertheless, due to the high infiltrating ability of glioblastoma cells, and regardless of the considerable progress made in radiotherapeutic, chemotherapeutic, and surgical protocols, the treatment of GBM is still inefficient. Conventional diagnostic approaches, such as neuroimaging techniques and tissue biopsies, which are invasive maneuvers, present certain challenges and limitations in providing real-time information, and are incapable of differentiating pseudo-progression related to treatment from real tumor progression. Liquid biopsy, the analysis of biomarkers such as nucleic acids (DNA/RNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), or tumor-educated platelets (TEPs) that are present in body fluids, provides a minimally invasive and dynamic method of diagnosis and continuous monitoring for GBM. It represents a new preferred approach that enables a superior manner to obtain data on possible tumor risk, prognosis, and recurrence assessment. This article is a literature review that aims to provide updated information about GBM biomarkers in body fluids and to analyze their clinical efficiency.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Clinicopathological Characteristics for HER2-Null, HER2-Ultralow and HER2-Low Breast Cancer: A Single-Center Study. her2阴性、her2超低和her2低乳腺癌临床病理特征的比较:一项单中心研究
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-13 DOI: 10.3390/medicina61040719
Seval Akay, Mumin Emiroglu, Canan Kelten Talu, Olcun Umit Unal

Background and Objectives: A recent clinical trial has demonstrated that breast cancer with low-HER2 expression levels responds to trastuzumab deruxtecan treatment. This has prompted a re-evaluation of HER2-targeted therapies in the HER2-negative group. Further research is required in the form of more detailed information about HER2-negative breast cancers with HER2-null, HER2-ultralow, and HER2-low subgroups. This study represents a novel approach to this field. Materials and Methods: HER2-negative breast cancer patients were classified into three groups as HER2-null, HER2-ultralow, and HER2-low. A comparison of clinicopathological features was analyzed retrospectively. Results: Of 722 patients, 22.3% were HER2-null, 23.7% were HER2-ultralow, 54.0% were HER2-low. While two-thirds of all the patients were evaluated as having T2 tumors, T4 tumors constituted 2.4%. Among HER2-negative cases, 11.8% were triple-negative and 88.2% were hormone-positive. The mean tumor diameter was 0.57 cm larger in the HER2-ultralow group than in the HER2-null group and 0.34 cm larger in the HER2-low group than in the HER2-null group. HER2-null tumors tend to be smaller. The HER2-low group was more likely to relapse than the HER2-null group. There were no significant differences in the distribution of hormone positivity or negativity (TNBC) among the groups; they accounted for 89.2% and 10.8% of all cases, respectively. Conclusions: HER2-negative breast cancer is a heterogeneous disease and deserves a detailed review in terms of diagnosis and treatment. HER2-ultralow tumors are larger in size and have a prognosis comparable to HER2-null tumors. HER2-low tumors tend to recur much more frequently and with poorer outcomes. In this field, new therapeutic approaches may result in better outcomes.

背景和目的:最近的一项临床试验表明,低her2表达水平的乳腺癌对曲妥珠单抗德鲁西替康治疗有反应。这促使在her2阴性组中重新评估her2靶向治疗。需要进一步研究her2阴性乳腺癌的her2无亚组、her2超低亚组和her2低亚组的更详细信息。这项研究代表了这一领域的一种新方法。材料与方法:将her2阴性乳腺癌患者分为her2阴性组、her2超低组和her2低组。回顾性分析两组患者的临床病理特征。结果:722例患者中,22.3%为her2阴性,23.7%为her2超低,54.0%为her2低。而三分之二的患者被评估为T2肿瘤,T4肿瘤占2.4%。在her2阴性病例中,11.8%为三阴性,88.2%为激素阳性。her2 -超低组肿瘤平均直径比her2 -无组大0.57 cm, her2 -低组肿瘤平均直径比her2 -无组大0.34 cm。her2阴性肿瘤往往较小。her2低组比her2无组更容易复发。各组间激素阳性或阴性(TNBC)分布差异无统计学意义;分别占全部病例的89.2%和10.8%。结论:her2阴性乳腺癌是一种异质性疾病,值得在诊断和治疗方面进行详细的综述。her2超低肿瘤体积更大,预后与her2无肿瘤相当。her2低的肿瘤往往更容易复发,预后也更差。在这个领域,新的治疗方法可能会带来更好的结果。
{"title":"Comparison of Clinicopathological Characteristics for HER2-Null, HER2-Ultralow and HER2-Low Breast Cancer: A Single-Center Study.","authors":"Seval Akay, Mumin Emiroglu, Canan Kelten Talu, Olcun Umit Unal","doi":"10.3390/medicina61040719","DOIUrl":"https://doi.org/10.3390/medicina61040719","url":null,"abstract":"<p><p><i>Background and Objectives</i>: A recent clinical trial has demonstrated that breast cancer with low-HER2 expression levels responds to trastuzumab deruxtecan treatment. This has prompted a re-evaluation of HER2-targeted therapies in the HER2-negative group. Further research is required in the form of more detailed information about HER2-negative breast cancers with HER2-null, HER2-ultralow, and HER2-low subgroups. This study represents a novel approach to this field. <i>Materials and Methods</i>: HER2-negative breast cancer patients were classified into three groups as HER2-null, HER2-ultralow, and HER2-low. A comparison of clinicopathological features was analyzed retrospectively. <i>Results</i>: Of 722 patients, 22.3% were HER2-null, 23.7% were HER2-ultralow, 54.0% were HER2-low. While two-thirds of all the patients were evaluated as having T2 tumors, T4 tumors constituted 2.4%. Among HER2-negative cases, 11.8% were triple-negative and 88.2% were hormone-positive. The mean tumor diameter was 0.57 cm larger in the HER2-ultralow group than in the HER2-null group and 0.34 cm larger in the HER2-low group than in the HER2-null group. HER2-null tumors tend to be smaller. The HER2-low group was more likely to relapse than the HER2-null group. There were no significant differences in the distribution of hormone positivity or negativity (TNBC) among the groups; they accounted for 89.2% and 10.8% of all cases, respectively. <i>Conclusions</i>: HER2-negative breast cancer is a heterogeneous disease and deserves a detailed review in terms of diagnosis and treatment. HER2-ultralow tumors are larger in size and have a prognosis comparable to HER2-null tumors. HER2-low tumors tend to recur much more frequently and with poorer outcomes. In this field, new therapeutic approaches may result in better outcomes.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Diabetes Mellitus and Hypertension During Hospitalization in Maxillofacial Departments. 颌面外科住院期间糖尿病和高血压的处理。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-12 DOI: 10.3390/medicina61040712
Andrei Krasovsky, Tal Capucha, Ragda Abdalla-Aslan, Nidal Zeineh, Amir Bilder, Ahmad Hija, Ori Blanc, Omri Emodi, Adi Rachmiel, Dekel Shilo

Background and Objectives: Diabetes mellitus (DM) and hypertension (HTN) continue to increase and pose a significant burden on the health system worldwide. These patients comprise a significant portion of the hospitalized Oral and Maxillofacial Surgery (OMFS) department. Addressing and controlling DM and HTN during hospitalization should thus be one of the treatment goals. This study aims to investigate the management and outcomes of DM and HTN during the hospitalization period in the OMFS department. Materials and Methods: A retrospective analysis of patients with community-diagnosed DM and/or HTN admitted to the OMFS department between 2017 and 2019 was conducted at Rambam Healthcare Campus, Haifa, Israel. Linear regression analysis was used to determine trends in changes in blood pressure and blood glucose levels during hospitalization. The impact of consults from internal medicine experts and endocrinologists was tested using a paired-samples t-test. Results: A statistically significant reduction was observed in all systolic HTN patients categorized as stages 1 and 2, p = 0.012 and p = 0.001, respectively. A statistically significant (p = 0.012) reduction in blood glucose levels in all DM patients with initial values higher than 250 mg/dL was observed. A statistically significant reduction in blood glucose levels was observed in the DM group of patients who received endocrinologist consultations (p = 0.012). Conclusions: Addressing patients with systemic conditions during hospitalization in the OMFS department is mandatory. External medical consulting can be of great value for short-term treatment during hospitalization and may also have long-term benefits after discharge to the community. The main limitations of this study include retrospective data acquisition, a small sample size, and a lack of data regarding the impact of pain management on blood pressure and glucose levels.

背景和目的:糖尿病(DM)和高血压(HTN)持续增加,并对全球卫生系统造成重大负担。这些患者占住院口腔颌面外科(OMFS)部门的很大一部分。因此,在住院期间处理和控制糖尿病和HTN应成为治疗目标之一。本研究旨在探讨OMFS科住院期间DM和HTN的处理及结局。材料和方法:回顾性分析2017年至2019年在以色列海法Rambam医疗保健校区的OMFS部门入院的社区诊断的DM和/或HTN患者。采用线性回归分析确定住院期间血压和血糖水平的变化趋势。来自内科专家和内分泌学家的咨询的影响使用配对样本t检验进行测试。结果:1期和2期收缩期HTN患者均有统计学意义的降低,p = 0.012和p = 0.001。所有初始值高于250 mg/dL的DM患者血糖水平均有统计学意义(p = 0.012)降低。在接受内分泌专家咨询的糖尿病组患者中,血糖水平有统计学意义的显著降低(p = 0.012)。结论:在OMFS部门住院期间处理全身性疾病的患者是强制性的。外部医疗咨询对住院期间的短期治疗有很大的价值,出院后对社区也可能有长期的好处。本研究的主要局限性包括回顾性数据采集,样本量小,以及缺乏关于疼痛管理对血压和血糖水平影响的数据。
{"title":"Management of Diabetes Mellitus and Hypertension During Hospitalization in Maxillofacial Departments.","authors":"Andrei Krasovsky, Tal Capucha, Ragda Abdalla-Aslan, Nidal Zeineh, Amir Bilder, Ahmad Hija, Ori Blanc, Omri Emodi, Adi Rachmiel, Dekel Shilo","doi":"10.3390/medicina61040712","DOIUrl":"https://doi.org/10.3390/medicina61040712","url":null,"abstract":"<p><p><i>Background and Objectives</i>: Diabetes mellitus (DM) and hypertension (HTN) continue to increase and pose a significant burden on the health system worldwide. These patients comprise a significant portion of the hospitalized Oral and Maxillofacial Surgery (OMFS) department. Addressing and controlling DM and HTN during hospitalization should thus be one of the treatment goals. This study aims to investigate the management and outcomes of DM and HTN during the hospitalization period in the OMFS department. <i>Materials and Methods</i>: A retrospective analysis of patients with community-diagnosed DM and/or HTN admitted to the OMFS department between 2017 and 2019 was conducted at Rambam Healthcare Campus, Haifa, Israel. Linear regression analysis was used to determine trends in changes in blood pressure and blood glucose levels during hospitalization. The impact of consults from internal medicine experts and endocrinologists was tested using a paired-samples <i>t</i>-test. <i>Results</i>: A statistically significant reduction was observed in all systolic HTN patients categorized as stages 1 and 2, <i>p</i> = 0.012 and <i>p</i> = 0.001, respectively. A statistically significant (<i>p</i> = 0.012) reduction in blood glucose levels in all DM patients with initial values higher than 250 mg/dL was observed. A statistically significant reduction in blood glucose levels was observed in the DM group of patients who received endocrinologist consultations (<i>p</i> = 0.012). <i>Conclusions</i>: Addressing patients with systemic conditions during hospitalization in the OMFS department is mandatory. External medical consulting can be of great value for short-term treatment during hospitalization and may also have long-term benefits after discharge to the community. The main limitations of this study include retrospective data acquisition, a small sample size, and a lack of data regarding the impact of pain management on blood pressure and glucose levels.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of Oncology: Drug-Induced Cardiac Toxicity. 肿瘤学综述:药物引起的心脏毒性。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-12 DOI: 10.3390/medicina61040709
Nilima Rajpal Kundnani, Vincenzo Passini, Iulia Stefania Carlogea, Patrick Dumitrescu, Vlad Meche, Roxana Buzas, Daniel Marius Duda-Seiman

Cancer medications can cause cardiac issues, which are difficult to treat in oncologic patients because of the risk of complications. In some cases, this may significantly impact their well-being and treatment outcomes. Overall, these complications fall under the term "drug induced cardiotoxicity", mainly due to chemotherapy drugs being specifically toxic to the heart, causing a decrease in the heart's capacity to pump blood efficiently and leading to a reduction in the left ventricular ejection fraction (LVEF), and subsequently possibly leading to heart failure. Anthracyclines, alkylating agents, and targeted therapies for cancer hold the potential of causing harmful effects on the heart. The incidence of heart-related issues varies from patient to patient and depends on multiple factors, including the type of medication, dosage, duration of the treatment, and pre-existing heart conditions. The underlying mechanism leading to oncologic-drug-induced cardiovascular harmful effects is quite complex. One particular group of drugs, called anthracyclines, have garnered attention due to their impact on oxidative stress and their ability to cause direct harm to heart muscle cells. Reactive oxygen species (ROS) cause harm by inducing damage and programmed cell death in heart cells. Conventional biomarkers alone can only indicate some degree of damage that has already occurred and, therefore, early detection is key. Novel methods like genetic profiling are being developed to detect individuals at risk, prior to the onset of clinical symptoms. Key management strategies-including early detection, personalized medicine approaches, and the use of novel biomarkers-play a crucial role in mitigating cardiotoxicity and improving patient outcomes. Identification of generated genetic alterations and the association to an increased likelihood of cardiotoxicity will allow treatment in a more personalized approach, aiming at decreasing rates of cardiac events while maintaining high oncological efficacy. Oncology drug-induced cardiotoxicity is managed through a combination of preventive strategies and therapeutic interventions from the union of cardiac and oncological knowledge.

癌症药物可能导致心脏问题,由于并发症的风险,这在肿瘤患者中很难治疗。在某些情况下,这可能会严重影响他们的健康和治疗结果。总的来说,这些并发症属于“药物性心脏毒性”,主要是由于化疗药物对心脏具有特异性毒性,导致心脏有效泵血能力下降,导致左心室射血分数(LVEF)降低,随后可能导致心力衰竭。蒽环类药物、烷基化剂和针对癌症的靶向治疗都有可能对心脏造成有害影响。心脏相关问题的发生率因患者而异,并取决于多种因素,包括药物类型、剂量、治疗持续时间和先前存在的心脏病。肿瘤药物致心血管损害的潜在机制相当复杂。有一类特殊的药物,被称为蒽环类药物,因其对氧化应激的影响和对心肌细胞造成直接伤害的能力而引起了人们的关注。活性氧(ROS)通过诱导心脏细胞损伤和程序性细胞死亡而造成危害。传统的生物标志物只能表明已经发生的一定程度的损害,因此早期检测是关键。正在开发诸如基因谱分析之类的新方法,以便在出现临床症状之前检测有风险的个体。关键的管理策略——包括早期检测、个性化医疗方法和新型生物标志物的使用——在减轻心脏毒性和改善患者预后方面发挥着至关重要的作用。识别产生的基因改变及其与心脏毒性可能性增加的关联,将允许采用更个性化的方法进行治疗,旨在降低心脏事件的发生率,同时保持较高的肿瘤疗效。肿瘤药物引起的心脏毒性是通过结合心脏和肿瘤知识的预防策略和治疗干预相结合来管理的。
{"title":"Overview of Oncology: Drug-Induced Cardiac Toxicity.","authors":"Nilima Rajpal Kundnani, Vincenzo Passini, Iulia Stefania Carlogea, Patrick Dumitrescu, Vlad Meche, Roxana Buzas, Daniel Marius Duda-Seiman","doi":"10.3390/medicina61040709","DOIUrl":"https://doi.org/10.3390/medicina61040709","url":null,"abstract":"<p><p>Cancer medications can cause cardiac issues, which are difficult to treat in oncologic patients because of the risk of complications. In some cases, this may significantly impact their well-being and treatment outcomes. Overall, these complications fall under the term \"drug induced cardiotoxicity\", mainly due to chemotherapy drugs being specifically toxic to the heart, causing a decrease in the heart's capacity to pump blood efficiently and leading to a reduction in the left ventricular ejection fraction (LVEF), and subsequently possibly leading to heart failure. Anthracyclines, alkylating agents, and targeted therapies for cancer hold the potential of causing harmful effects on the heart. The incidence of heart-related issues varies from patient to patient and depends on multiple factors, including the type of medication, dosage, duration of the treatment, and pre-existing heart conditions. The underlying mechanism leading to oncologic-drug-induced cardiovascular harmful effects is quite complex. One particular group of drugs, called anthracyclines, have garnered attention due to their impact on oxidative stress and their ability to cause direct harm to heart muscle cells. Reactive oxygen species (ROS) cause harm by inducing damage and programmed cell death in heart cells. Conventional biomarkers alone can only indicate some degree of damage that has already occurred and, therefore, early detection is key. Novel methods like genetic profiling are being developed to detect individuals at risk, prior to the onset of clinical symptoms. Key management strategies-including early detection, personalized medicine approaches, and the use of novel biomarkers-play a crucial role in mitigating cardiotoxicity and improving patient outcomes. Identification of generated genetic alterations and the association to an increased likelihood of cardiotoxicity will allow treatment in a more personalized approach, aiming at decreasing rates of cardiac events while maintaining high oncological efficacy. Oncology drug-induced cardiotoxicity is managed through a combination of preventive strategies and therapeutic interventions from the union of cardiac and oncological knowledge.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144038286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination of Individual Tests to Improve Diagnostic Accuracy in Chlamydia trachomatis Detection. 结合单项检测提高沙眼衣原体检测的诊断准确性。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-12 DOI: 10.3390/medicina61040714
Jelena Tošić-Pajić, Predrag Sazdanović, Aleksandar Nikolov, Dragan R Milovanović, Violeta Ninković, Jelena Čukić, Slobodan Subotić, Marija Šorak, Dejan Baskić

Background and Objectives: Chlamydial infection is the most common asymptomatic infection worldwide. Despite all national programs, strategies and guidelines, chlamydial infection is still the leading infection worldwide, especially in young populations. We have tried to summarize the best diagnostic tools for its detection. Materials and Methods: In the study, 225 sexually active patients who were tested for chlamydial infection at the Institute of Public Health Kragujevac participated. Results: Combinations of direct immunofluorescence (DIF) and a rapid lateral immunochromatographic test (RT) and combinations of an RT and immunoglobulin G (IgG) do not improve diagnostic efficiency when compared to a rapid test that individually had the best parameters. In situations that require high specificity, the recommended combination is RT/IgA, which as a highly specific test has few false positive results, while the combinations of DIF + RT and RT + IgG, although showing a specificity of 100%, have low sensitivity (33.30%), due to which we prefer the RT/IgA combination. The combinations DIF + RT, DIF + RT + IgG and RT + IgG, although with low sensitivity, have the highest values of specificity, and the positive predictive value (PPV) and negative predictive value (NPV) show the highest values of the extended Youden index of 130.30% and the highest values of total diagnostic accuracy of 97.00%. Based on the results of the extended Youden index, taking into account PPV and NPV, the RT/IgA combination shows the highest value of 94.60%, as well as the highest value of total diagnostic accuracy of 93.00%. Conclusions: "Two or more positive tests" or "any test positive" did not improve the diagnostic efficiency compared to a single "rapid test".

背景与目的:衣原体感染是世界范围内最常见的无症状感染。尽管有所有的国家规划、战略和指南,衣原体感染仍然是世界范围内的主要感染,特别是在年轻人群中。我们试图总结最好的诊断工具来检测它。材料和方法:在这项研究中,225名性活跃患者在克拉古耶瓦茨公共卫生研究所接受了衣原体感染检测。结果:与单独具有最佳参数的快速检测相比,直接免疫荧光(DIF)和快速侧免疫层析(RT)的组合以及RT和免疫球蛋白G (IgG)的组合并不能提高诊断效率。在对特异性要求较高的情况下,推荐采用RT/IgA联合检测,其特异性高,假阳性结果少,而DIF + RT和RT + IgG联合检测虽然特异性为100%,但敏感性较低(33.30%),因此我们更倾向于采用RT/IgA联合检测。DIF + RT、DIF + RT + IgG和RT + IgG组合虽然敏感性较低,但特异性值最高,阳性预测值(PPV)和阴性预测值(NPV)的扩展约登指数最高为130.30%,总诊断准确率最高为97.00%。根据扩展约登指数的结果,综合PPV和NPV, RT/IgA联合的诊断准确率最高,为94.60%,总诊断准确率最高,为93.00%。结论:与单一的“快速检测”相比,“两次或两次以上阳性检测”或“任何检测阳性”均不能提高诊断效率。
{"title":"Combination of Individual Tests to Improve Diagnostic Accuracy in <i>Chlamydia trachomatis</i> Detection.","authors":"Jelena Tošić-Pajić, Predrag Sazdanović, Aleksandar Nikolov, Dragan R Milovanović, Violeta Ninković, Jelena Čukić, Slobodan Subotić, Marija Šorak, Dejan Baskić","doi":"10.3390/medicina61040714","DOIUrl":"https://doi.org/10.3390/medicina61040714","url":null,"abstract":"<p><p><i>Background and Objectives</i>: Chlamydial infection is the most common asymptomatic infection worldwide. Despite all national programs, strategies and guidelines, chlamydial infection is still the leading infection worldwide, especially in young populations. We have tried to summarize the best diagnostic tools for its detection. <i>Materials and Methods</i>: In the study, 225 sexually active patients who were tested for chlamydial infection at the Institute of Public Health Kragujevac participated. <i>Results</i>: Combinations of direct immunofluorescence (DIF) and a rapid lateral immunochromatographic test (RT) and combinations of an RT and immunoglobulin G (IgG) do not improve diagnostic efficiency when compared to a rapid test that individually had the best parameters. In situations that require high specificity, the recommended combination is RT/IgA, which as a highly specific test has few false positive results, while the combinations of DIF + RT and RT + IgG, although showing a specificity of 100%, have low sensitivity (33.30%), due to which we prefer the RT/IgA combination. The combinations DIF + RT, DIF + RT + IgG and RT + IgG, although with low sensitivity, have the highest values of specificity, and the positive predictive value (PPV) and negative predictive value (NPV) show the highest values of the extended Youden index of 130.30% and the highest values of total diagnostic accuracy of 97.00%. Based on the results of the extended Youden index, taking into account PPV and NPV, the RT/IgA combination shows the highest value of 94.60%, as well as the highest value of total diagnostic accuracy of 93.00%. <i>Conclusions</i>: \"Two or more positive tests\" or \"any test positive\" did not improve the diagnostic efficiency compared to a single \"rapid test\".</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144056361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Relationship Between Participation in Leisure Sports Activities, Health Behaviors, and Life Satisfaction Among Older Adults with Disabilities. 残障老年人休闲体育活动参与、健康行为与生活满意度的关系研究。
IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-12 DOI: 10.3390/medicina61040713
Seungok An, Su-Yeon Roh, Jeonga Kwon

Background and Objectives: As the world enters an aging society, it is necessary to focus on older individuals, especially those with disabilities. The latter must face two issues, their disability and their age; therefore, a lot of attention must be paid to their health. In this study, we aimed to explore the association between participation in leisure sports activities, health behaviors, and life satisfaction among older adults with disabilities. The research question we aimed to address was as follows: Can participation in leisure sports activities positively affect the health behaviors and life satisfaction of older adults with disabilities? Materials and Methods: Data were sourced from the 2023 Survey on the Status of Persons with Disabilities organized by the Korea Ministry of Health and Welfare. The collected data were analyzed using frequency analyses, chi-squared tests, and multivariate logistic regression analyses. Results: Multivariate logistic regression analyses revealed that regarding sex, the average odds ratio (OR) was 1.525 (p = 0.001) for males. Regarding efforts to control weight, the average OR was 1.808 (p < 0.001) for "tried to reduce", 1.893 (p < 0.001) for "tried to maintain", and 1.245 (p = 0.345) for "tried to increase". Regarding smoking, the average OR was 0.612 (p = 0.008) for "smoke daily", 0.947 (p = 0.889) for "smoke occasionally", and 1.175 (p = 0.255) for "smoked in the past but do not smoke now". Regarding health status satisfaction, the average OR was 2.014 (p = 0.022) for very satisfied, 1.846 (p = 0.013) for somewhat satisfied, and 1.347 (p = 0.220) for somewhat dissatisfied. Regarding friendship satisfaction, the average OR was 9.177 (p < 0.001) for very satisfied, 5.428 (p < 0.001) for somewhat satisfied, and 3.024 (p = 0.011) for somewhat dissatisfied. Namely, participation in leisure sports activities was significantly related to weight control efforts, smoking cessation, increased health status satisfaction, and increased friendship satisfaction among older adults with disabilities. Conclusions: Access to leisure sports activities should be increased to improve the health of older adults with disabilities. Furthermore, leisure sports activities should be considered in the establishment of policies and services to enhance the health of these individuals.

背景和目的:随着世界进入老龄化社会,有必要关注老年人,特别是残疾人。后者必须面对两个问题:残疾和年龄;因此,必须非常重视他们的健康。本研究旨在探讨残障老年人参与休闲体育活动、健康行为与生活满意度之间的关系。我们的研究问题是:参与休闲体育活动是否会对残疾老年人的健康行为和生活满意度产生积极影响?资料和方法:数据来源于韩国保健福利部组织的《2023年残疾人状况调查》。收集的资料采用频率分析、卡方检验和多变量logistic回归分析进行分析。结果:多因素logistic回归分析显示,在性别方面,男性的平均优势比(OR)为1.525 (p = 0.001)。关于控制体重的努力,“试图减少体重”的平均OR为1.808 (p < 0.001),“试图保持体重”的平均OR为1.893 (p < 0.001),“试图增加体重”的平均OR为1.245 (p = 0.345)。在吸烟方面,“每天吸烟”的平均OR为0.612 (p = 0.008),“偶尔吸烟”的平均OR为0.947 (p = 0.889),“过去吸烟但现在不吸烟”的平均OR为1.175 (p = 0.255)。健康状况满意度方面,“非常满意”的平均OR为2.014 (p = 0.022),“一般满意”的平均OR为1.846 (p = 0.013),“一般不满意”的平均OR为1.347 (p = 0.220)。在友谊满意度方面,“非常满意”的平均OR为9.177 (p < 0.001),“比较满意”的平均OR为5.428 (p < 0.001),“比较不满意”的平均OR为3.024 (p = 0.011)。也就是说,参加休闲体育活动与控制体重、戒烟、增加健康状况满意度和增加友谊满意度显著相关。结论:应增加老年人的休闲体育活动,以改善老年人的健康状况。此外,在制定促进这些人健康的政策和服务时,应考虑到休闲体育活动。
{"title":"Exploring the Relationship Between Participation in Leisure Sports Activities, Health Behaviors, and Life Satisfaction Among Older Adults with Disabilities.","authors":"Seungok An, Su-Yeon Roh, Jeonga Kwon","doi":"10.3390/medicina61040713","DOIUrl":"https://doi.org/10.3390/medicina61040713","url":null,"abstract":"<p><p><i>Background and Objectives</i>: As the world enters an aging society, it is necessary to focus on older individuals, especially those with disabilities. The latter must face two issues, their disability and their age; therefore, a lot of attention must be paid to their health. In this study, we aimed to explore the association between participation in leisure sports activities, health behaviors, and life satisfaction among older adults with disabilities. The research question we aimed to address was as follows: Can participation in leisure sports activities positively affect the health behaviors and life satisfaction of older adults with disabilities? <i>Materials and Methods</i>: Data were sourced from the 2023 Survey on the Status of Persons with Disabilities organized by the Korea Ministry of Health and Welfare. The collected data were analyzed using frequency analyses, chi-squared tests, and multivariate logistic regression analyses. <i>Results</i>: Multivariate logistic regression analyses revealed that regarding sex, the average odds ratio (OR) was 1.525 (<i>p</i> = 0.001) for males. Regarding efforts to control weight, the average OR was 1.808 (<i>p</i> < 0.001) for \"tried to reduce\", 1.893 (<i>p</i> < 0.001) for \"tried to maintain\", and 1.245 (<i>p</i> = 0.345) for \"tried to increase\". Regarding smoking, the average OR was 0.612 (<i>p</i> = 0.008) for \"smoke daily\", 0.947 (<i>p</i> = 0.889) for \"smoke occasionally\", and 1.175 (<i>p</i> = 0.255) for \"smoked in the past but do not smoke now\". Regarding health status satisfaction, the average OR was 2.014 (<i>p</i> = 0.022) for very satisfied, 1.846 (<i>p</i> = 0.013) for somewhat satisfied, and 1.347 (<i>p</i> = 0.220) for somewhat dissatisfied. Regarding friendship satisfaction, the average OR was 9.177 (<i>p</i> < 0.001) for very satisfied, 5.428 (<i>p</i> < 0.001) for somewhat satisfied, and 3.024 (<i>p</i> = 0.011) for somewhat dissatisfied. Namely, participation in leisure sports activities was significantly related to weight control efforts, smoking cessation, increased health status satisfaction, and increased friendship satisfaction among older adults with disabilities. <i>Conclusions</i>: Access to leisure sports activities should be increased to improve the health of older adults with disabilities. Furthermore, leisure sports activities should be considered in the establishment of policies and services to enhance the health of these individuals.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12029062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144062986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina-Lithuania
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1